| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 11 |
| 1 | GLATIRAMER ACETATE | 10 |
| 2 | ARIPIPRAZOLE LAUROXIL | 6 |
| 3 | NALTREXONE | 6 |
| 4 | CABOTEGRAVIR | 5 |
| 5 | DENOSUMAB | 5 |
| 6 | RILPIVIRINE | 5 |
| 7 | SIMVASTATIN | 5 |
| 8 | ACETAMINOPHEN | 4 |
| 9 | ERGOCALCIFEROL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARIPIPRAZOLE LAUROXIL | 6 | 0.0013 |
| 1 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 2 | DILUENT | 1 | 0.0010 |
| 3 | RILPIVIRINE | 5 | 0.0007 |
| 4 | CABOTEGRAVIR SODIUM | 1 | 0.0006 |
| 5 | CABOTEGRAVIR | 5 | 0.0006 |
| 6 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 1 | 0.0005 |
| 7 | GLATIRAMER ACETATE INJECTION | 2 | 0.0004 |
| 8 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 | 0.0003 |
| 9 | CABOTEGRAVIR AND RILPIVIRINE | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 2 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 4 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 5 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 8 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |